A method for protecting human arterial endothelial cells from endothelial cell dysfunction. The method includes administering a pharmaceutically effective amount of a composition over a sufficient period of time to stimulate the endothelial cells themselves to produce NO resulting in the protection of the endothelial cells and the vasculature from endothelial cell dysfunction.
A method for protecting human arterial endothelial cells from endothelial cell dysfunction. The method includes administering a pharmaceutically effective amount of a composition over a sufficient period of time to stimulate NOS and protecting human arterial endothelial cells from endothelial cell dysfunction.
A method for protecting human arterial endothelial cells from endothelial cell dysfunction. The method includes administering a pharmaceutically effective amount of a composition over a sufficient period of time to stimulate NOS and protecting human arterial endothelial cells from endothelial cell dysfunction.
A method for treatment of constipation and other ailments of the gastrointestinal system includes administering a pharmaceutically effective amount of a composition over a sufficient period of time that results in the production of nitric oxide in gastrointestinal cells and ultimately has beneficial results in treating constipation and other ailments of the gastrointestinal system. The composition comprises ginger or a ginger derivative, muira puama, and paullinia cupana that stimulates nitric oxide in gastrointestinal cells to increase NO and improve bowel functioning thereof.
A23G 4/12 - Chewing gum characterised by the composition containing microorganisms or enzymesChewing gum characterised by the composition containing paramedical or dietetical agents, e.g. vitamins
Compositions and methods for treating, inhibiting the onset, and slowing the progression of erectile dysfunction including naturally occurring age related erectile dysfunction
Fructus aurantil immaturus (FAI). The compositions of the present inventions are administered in a pharmaceutically effective amount to treat erectile dysfunction. Essential ingredients in formulations of the present inventions for treatment of ED and ARED are ginger (or ginger derivative) and L-citrulline or L-arginine. A daily dosage of at least about 250 mg ginger and at least about 400 mg L-citrulline or L-arginine for a sufficient period of time will result in improved IIEF scores in a substantial number of patients.
A composition for enhancing treatment of orthopedic ailments stimulates iNOS and enhances treatment of orthopedic ailments when a pharmaceutically effective amount is administered over a sufficient period of time. The composition comprises ginger, Muira puama, Paullinia cupana, and at least one of the group consisting of L-arginine and L-citrulline.
The duration of treatment of erectile dysfunction ("ED") with phosphodiesterase inhibitors can be extended by concomitant administrations of compositions comprising ginger, and a compound that produces L-arginine in vivo. Preferred compositions of the present invention comprise ginger, L-citrulline, Muira Puama and Paullinia cupana. The compositions are administered in a pharmaceutically effective amount for a sufficient period of time to treat or as a prophylaxis against ED or conditions associated with tissue fibrosis.
A61K 36/77 - Sapindaceae (Soapberry family), e.g. lychee or soapberry
A61P 15/10 - Drugs for genital or sexual disordersContraceptives for impotence
10.
Compositions and methods for treating, inhibiting the onset, and slowing the progression of erectile dysfunction including naturally occurring age related erectile dysfunction
Paullinia cupana), Muira puama cortex magnoliae officinalis (CMO) and/or fructus aurantil immaturus (FAI). The compositions of the present inventions are administered in a pharmaceutically effective amount to treat erectile dysfunction. Essential ingredients in formulations of the present inventions for treatment of ED and ARED are ginger (or ginger derivative) and L-citrulline or L-arginine. A daily dosage of at least about 250 mg ginger and at least about 400 mg L-citrulline or L-arginine for a sufficient period of time will result in improved IIEF scores in a substantial number of patients.
Compositions for treating erectile dysfunction ("ED"), including age related erectile dysfunction (ARED), comprise in a preferred embodiment ginger and an amino acid. Preferably the amino acid is L-arginine and/or L-citrulline. Additionally, the compositions may comprise guarana (Paullinia cupana), Muira puama cortex magnoliae officinalis (CMO) and/or fructus aurantil immaturus (FAI). A daily dosage of at least about 250 mg ginger (or ginger derivative) and at least about 400 mg L-citrulline or L-arginine (or a mixture of L- citrulline and L-arginine) for a sufficient period of time (e.g., at least 30 days) will result in improved IIEF scores in a substantial number of patients that are experiencing ED or ARED and/or will result in maintenance of IIEF scores for patients that might otherwise experienced a decrease in IIEF scrores.
A01N 65/00 - Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
patents
